Literature DB >> 29129543

Idiopathic elastosis perforans serpiginosa with satisfactory response after 5-ALA photodynamic therapy.

S Alique-García1, J Company-Quiroga2, C Horcajada-Reales2, B Echeverría-García2, J C Tardío-Dovao3, J Borbujo2.   

Abstract

Photodynamic therapy (PDT) involves the use of photochemical reactions mediated through the interaction of photosensitizing agents, light, and oxygen for the treatment of malignant or benign diseases. Topical photosensitizers employed in dermatology are 5-aminolevulinic acid (5 ALA) and methyl aminolevulinate, classically used for the treatment of superficial non-melanoma skin cancer and their precursors. Recently the efficacy of PDT has been introduced in other benign diseases. Elastosis perforans serpiginosa (EPS) is a rare skin disorder characterized by transepidermal elimination of abnormal elastic fibers. Management of this condition is complicated, various methods have been used but with limited success. We report a case of EPS in a 30-yeard-old woman treated with 5 ALA-PDT. After 4 sessions the lesions have almost completely disappeared with no residual side effects. Therefore we present an effective and safe alternative for the treatment of EPS.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  5-Aminolevulinic acid; Elastosis perforans serpiginosa; Photodynamic therapy

Mesh:

Substances:

Year:  2017        PMID: 29129543     DOI: 10.1016/j.pdpdt.2017.11.001

Source DB:  PubMed          Journal:  Photodiagnosis Photodyn Ther        ISSN: 1572-1000            Impact factor:   3.631


  1 in total

Review 1.  The Dark Side: Photosensitizer Prodrugs.

Authors:  Sara Sansaloni-Pastor; Jordan Bouilloux; Norbert Lange
Journal:  Pharmaceuticals (Basel)       Date:  2019-10-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.